Medscape

Stability of Pantoprazole in an Extemporaneously Compounded Oral Liquid

Pantoprazole is used for the shortterm treatment of erosive esophagitis associated with gastroesophageal reflux disease. [2] It is available as a lyophilized powder for injection in 10-mL glass vials ...
Monthly Prescribing Reference

FDA Greenlights Ibuprofen Oral Suspension Compounding to Help With Hospital Supply

Credit: Getty Images. Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance. In an effort to increase the ...
Stacker on MSN

Are Ozempic and Wegovy knock-offs safe? What to know about compounded GLP-1s

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

Azurity Pharmaceuticals Announces the Availability of JAVADIN™ (clonidine hydrochloride) Oral Solution

Approved, Ready-to-Use Clonidine Oral Solution for Hypertension Control in Adult PatientsWoburn, MA, Dec. 18, 2025 (GLOBE ...
Monthly Prescribing Reference

FDA Approves Imatinib Oral Solution Imkeldi

Imkeldi is supplied as a strawberry-flavored oral solution in a 140mL child resistant tamper-evident bottle. The Food and Drug Administration (FDA) has approved Imkeldi, an oral solution formulation ...
Nasdaq

FDA Approves ArbliTM, the First Ready-to-Use Oral Liquid Formulation of Losartan, from Scienture Holdings, Inc.

Scienture Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its liquid formulation of losartan, branded as ArbliTM (losartan potassium) Oral Suspension, at a ...